Hyperkalemia: The new killer?;L'hyperkaliémie, ce nouveau tueur?

Revue Medicale de Liege

Volumn 60, Issue 4, 2005, Pages 222-226

  Krzesinski, J M ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Antiinflammatory drugs; Drug interactions; Heart failure; Hyperkalemia; K sparing drugs; Renal failure

Indexed keywords

ANTIINFLAMMATORY AGENT; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE;

AGING; ANTIINFLAMMATORY ACTIVITY; DIABETES MELLITUS; HEART FAILURE; HYPERKALEMIA; KIDNEY FAILURE; POTASSIUM CONDUCTANCE; REVIEW; RISK FACTOR;

HUMANS; HYPERKALEMIA; RISK FACTORS;

EID: 19044398104     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Neven I, Krzesinski JM.- Comment j'explore ... un trouble de la kaliémie. Rev Med Liège, 1999, 54, 12, 943-947.
2. Neven I, Krzesinski JM.- Comment je traite . . . un trouble de la kaliémie. Rev Med Liège, 2000, 55, 1, 4-7.
3. Juurlink D, Mamdani M, Lee D. et al.- Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med, 2004, 351, 543-551.
4. Palmer B.- Current concepts: hyperkaliemia due to inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med, 2004, 351, 585-592.
5. Gross P, Pistrosch F.- Hyperkalaemia: again. Nephrol Dial Transplant, 2004, 19, 2163-2166.
6. Pitt B, Zannad F, Remme WJ et al.- The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med, 1999, 341, 709-717.
7. Pitt B, Remme WJ, Zannad F et al.- Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med, 2003, 348, 1309-1321.
8. Krzesinski JM, Piront R- Décompensation cardiaque, fonction rénale et anti-inflammatoires non stéroïdiens. Rev Med Liègt, 2002, 57, 9, 582-586.
9. Delanaye P, Chapelle JP, Ferir AM et al.- La mesure du dẃbit de filtration glomérulaire en clinique quotidienne. Rev Med Liège, 2003, 58, 2, 95-100.